Skip to main content

Type 2 diabetes and retinopathy

medwireNews

09-20-2023 | Latent autoimmune diabetes of adulthood | News

Latent autoimmune diabetes carries mortality and CVD risks comparable to type 2 diabetes

Latent autoimmune diabetes in adults is associated with similar risks for mortality and cardiovascular disease and an increased risk for retinopathy compared with type 2 diabetes.

01-17-2023 | Lifestyle interventions | News

Healthy lifestyle wards off type 2 diabetes microvascular complications

Real-world data from the UK Biobank show the value of a healthy lifestyle in people with type 2 diabetes hoping to avoid microvascular complications.

09-09-2022 | COVID-19 | News

Microvascular complications linked to COVID-19 mortality risk in people with type 2 diabetes

Study findings suggest that the presence of microvascular complications is associated with increased risk for all-cause mortality in people with type 2 diabetes hospitalized for COVID-19.

07-14-2022 | Retinopathy | News

‘Step therapy’ compromise preserves good outcomes in diabetic macular edema

Starting people on bevacizumab and switching to aflibercept only when necessary keeps costs down without compromising treatment efficacy for people with diabetic macular edema, shows a randomized trial.

04-14-2022 | Prediabetes | News

Retinal microvascular damage evident before type 2 diabetes diagnosis

People with hypertension and prediabetes have significantly lower capillary density in the foveal retinal region, indicating microvascular damage, than those with hypertension but normal glucose metabolism, say researchers.

01-28-2022 | Retinopathy | News

Intravitreal faricimab shows potential for diabetic macular edema

The dual Ang-2 and VEGF-A pathway inhibitor faricimab is noninferior to aflibercept for improving visual acuity in people with diabetic macular edema, and an individualized dosing strategy could help reduce treatment burden, suggest findings from the YOSEMITE and RHINE trials.

Early pregancy exam

12-03-2021 | Pregnancy | News

Microvascular diabetes complications linked to adverse pregnancy outcomes

Among pregnant women with preexisting diabetes, those with nephropathy or retinopathy may be at increased risk for pregnancy complications, suggest findings from a systematic review and meta-analysis.

10-29-2021 | Retinopathy | News

Sight-threatening retinopathy an early risk for youth-onset type 2 diabetes

Almost half of people diagnosed with type 2 diabetes in childhood develop retinopathy by their mid-20s, show TODAY2 data.

09-15-2021 | Retinopathy | News

Risk factors for early retinopathy in type 2 diabetes revealed

Factors including insulin use and ethnicity can help predict who will develop proliferative diabetic retinopathy within 5 years after type 2 diabetes diagnosis, say researchers.

Weekly pillbox

05-04-2021 | Medications | News

Objective assessment of medication taking advised to reduce type 2 diabetes complications

Suboptimal medication-taking identified through urine testing is associated with a higher prevalence of microvascular and macrovascular complications in people with type 2 diabetes than found with consistent usage, report researchers.

12-16-2020 | Aflibercept | News

Similar visual outcomes may be achieved with aflibercept vs vitrectomy

Intravitreous aflibercept and vitrectomy with panretinal laser photocoagulation appear to have similar efficacy over 24 weeks when used for the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, researchers report.

11-05-2020 | Retinopathy | News

Retinopathy screening attendance ‘suboptimal’ in young adults with diabetes

Results from a UK retrospective study suggest that there is “considerable variation” in diabetic eye screening attendance in different age groups, with the worse attendance rates among younger people.

Cartoon of overweight man walking on a 'cardiovascular tightrope'

05-05-2020 | Prediabetes | Highlight | News

Prediabetes marks increased vascular risk

People who meet the criteria for prediabetes during the 3 years before a type 2 diabetes diagnosis have a higher burden of vascular disease than those who do not, research shows.

02-25-2020 | Retinopathy | News

Eye problems present a particular risk for patients with young-onset type 2 diabetes

Young people with type 2 diabetes may be predisposed to developing retinal complications, Australian researchers warn.

Open window

02-10-2020 | Latent autoimmune diabetes of adulthood | Highlight | News

‘Early therapeutic window’ highlighted for LADA

Optimal glycemic control during the first years after a latent autoimmune diabetes of adulthood diagnosis could prevent people’s microvascular complication risk from equaling that seen in those with type 2 diabetes, shows an analysis of the UKPDS.

01-24-2020 | Obesity | News

Severe obesity may be associated with impaired cognition

Severely obese people show evidence of impaired cognition even when they have no signs of prediabetes or diabetes, but retinopathy and nephropathy only occur in those with hyperglycemia, US research shows.

08-14-2019 | Retinopathy | News

Offline, smartphone-based imaging accurately detects diabetic retinopathy

An offline, smartphone-based, nonmydriatic retinal imaging system accurately detects referable diabetic retinopathy when used by minimally trained operators in a point of care setting, show data from a pilot study carried out in India.

06-09-2019 | Type 2 diabetes | ADA 2019 | News

Short-term delays in diabetes onset confer long-term cardioprotective effects

Delaying diabetes onset by at least 6 years in people with impaired glucose tolerance significantly reduces their risk for cardiovascular disease and microvascular complications, show 30-year data from the Da Qing Diabetes Prevention Study.

05-01-2019 | Retinopathy | News

No rush to treat diabetic macular edema with good visual acuity

Research published in JAMA shows similar outcomes for patients with center-involved diabetic macular edema and good visual acuity over the first 2 years after diagnosis, regardless of whether they are managed with aflibercept, laser photocoagulation, or observation.

03-21-2019 | Heart failure | News

Microvascular disease a marker of heart failure risk in type 2 diabetes

The presence of microvascular disease in people with type 2 diabetes signals a high risk for heart failure, report the EMPA-REG OUTCOME investigators.